Phase 1 Adenoma Clinical Trials
7 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
Familial Adenomatous Polyposis
Recursion Pharmaceuticals Inc.67 enrolled17 locationsNCT05552755
Recruiting
Phase 1
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Colorectal CarcinomaFamilial Adenomatous PolyposisColorectal Adenomatous Polyp+1 more
National Cancer Institute (NCI)36 enrolled5 locationsNCT05630794
Recruiting
Phase 1Phase 2
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
Colorectal Cancer (CRC)Metastatic Colorectal Carcinoma (mCRC)Adenomatous Polyposis Coli (APC) Gene Mutation+1 more
HonorHealth Research Institute126 enrolled1 locationNCT07463599
Recruiting
Phase 1
Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas
Pituitary Adenoma
Mayo Clinic5 enrolled1 locationNCT07456878
Recruiting
Phase 1
Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
Colorectal AdenomaColorectal Cancer Prevention
Massachusetts General Hospital20 enrolled1 locationNCT07095517
Recruiting
Phase 1
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
MelanomaSolid TumorSolid Tumor, Adult+3 more
Rise Therapeutics LLC33 enrolled1 locationNCT06398418
Recruiting
Phase 1Phase 2
Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism
Primary AldosteronismPrimary Aldosteronism Due to Aldosterone Producing Adenoma
Peking Union Medical College Hospital150 enrolled1 locationNCT06773663